12.68 USD
-0.08 (-0.63%)
12.68 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to VTRS. VTRS was compared to 190 industry peers in the Pharmaceuticals industry. VTRS has a medium profitability rating, but doesn't score so well on its financial health evaluation. VTRS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year VTRS was profitable.
In the past year VTRS had a positive cash flow from operations.
In multiple years VTRS reported negative net income over the last 5 years.
In the past 5 years VTRS always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of -9.73%, VTRS is doing good in the industry, outperforming 66.84% of the companies in the same industry.
VTRS has a Return On Equity of -24.26%. This is in the better half of the industry: VTRS outperforms 64.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.41%, VTRS belongs to the top of the industry, outperforming 80.53% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VTRS is significantly below the industry average of 12.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROIC | 3.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
VTRS has a better Operating Margin (9.34%) than 82.11% of its industry peers.
In the last couple of years the Operating Margin of VTRS has declined.
VTRS has a better Gross Margin (39.36%) than 61.58% of its industry peers.
VTRS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VTRS is destroying value.
The number of shares outstanding for VTRS has been reduced compared to 1 year ago.
The number of shares outstanding for VTRS has been increased compared to 5 years ago.
The debt/assets ratio for VTRS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.95, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
VTRS has a Altman-Z score (0.95) which is comparable to the rest of the industry.
VTRS has a debt to FCF ratio of 8.96. This is a slightly negative value and a sign of low solvency as VTRS would need 8.96 years to pay back of all of its debts.
The Debt to FCF ratio of VTRS (8.96) is better than 80.00% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
VTRS has a Debt to Equity ratio of 0.82. This is in the lower half of the industry: VTRS underperforms 72.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 0.95 |
ROIC/WACC0.42
WACC8.06%
2.3 Liquidity
A Current Ratio of 1.35 indicates that VTRS should not have too much problems paying its short term obligations.
VTRS's Current ratio of 1.35 is on the low side compared to the rest of the industry. VTRS is outperformed by 75.26% of its industry peers.
VTRS has a Quick Ratio of 1.35. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
VTRS has a worse Quick ratio (0.79) than 83.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
The Earnings Per Share has been decreasing by -9.73% on average over the past years.
The Revenue has decreased by -6.14% in the past year.
The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
VTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.45% yearly.
VTRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.49% yearly.
EPS Next Y-10.8%
EPS Next 2Y-2.48%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue Next Year-4.73%
Revenue Next 2Y-1.82%
Revenue Next 3Y-0.58%
Revenue Next 5Y0.49%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.44, the valuation of VTRS can be described as very cheap.
Based on the Price/Earnings ratio, VTRS is valued cheaply inside the industry as 95.79% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.25. VTRS is valued rather cheaply when compared to this.
VTRS is valuated cheaply with a Price/Forward Earnings ratio of 5.03.
Based on the Price/Forward Earnings ratio, VTRS is valued cheaper than 96.32% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.98, VTRS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.44 | ||
| Fwd PE | 5.03 |
4.2 Price Multiples
93.68% of the companies in the same industry are more expensive than VTRS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VTRS is valued cheaper than 92.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.06 | ||
| EV/EBITDA | 6.8 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.48%
EPS Next 3Y1.45%
5. Dividend
5.1 Amount
VTRS has a Yearly Dividend Yield of 3.81%.
Compared to an average industry Dividend Yield of 0.35, VTRS pays a better dividend. On top of this VTRS pays more dividend than 96.32% of the companies listed in the same industry.
VTRS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.81% |
5.2 History
VTRS has paid a dividend for at least 10 years, which is a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y-2.48%
EPS Next 3Y1.45%
12.68
-0.08 (-0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.94%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change0.07%
Market Cap14.60B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts72.22
Price Target12.71 (0.24%)
Short Float %2.43%
Short Ratio3.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.81% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)2.62%
PT rev (3m)12.88%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-1.81%
EPS NY rev (1m)0.03%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.44 | ||
| Fwd PE | 5.03 | ||
| P/S | 1.03 | ||
| P/FCF | 9.06 | ||
| P/OCF | 7.37 | ||
| P/B | 0.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.8 |
EPS(TTM)2.33
EY18.38%
EPS(NY)2.52
Fwd EY19.88%
FCF(TTM)1.4
FCFY11.03%
OCF(TTM)1.72
OCFY13.58%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROCE | 4.32% | ||
| ROIC | 3.41% | ||
| ROICexc | 3.53% | ||
| ROICexgc | 14.83% | ||
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% | ||
| FCFM | 11.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 13.37% | ||
| Cap/Sales | 2.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 0.95 |
F-Score4
WACC8.06%
ROIC/WACC0.42
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.8%
EPS Next 2Y-2.48%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.73%
Revenue Next 2Y-1.82%
Revenue Next 3Y-0.58%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-4.99%
EBIT Next 3Y0.95%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
What is the valuation status for VTRS stock?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
What is the valuation of VIATRIS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for VIATRIS INC (VTRS) is 5.44 and the Price/Book (PB) ratio is 0.96.
How sustainable is the dividend of VIATRIS INC (VTRS) stock?
The dividend rating of VIATRIS INC (VTRS) is 5 / 10 and the dividend payout ratio is -15.34%.